Ditelluride-bridged, ROS-responsive nanoparticles based on carboxymethyl chitosan for potentiating doxorubicin chemotherapy

Biomedical Materials 2026

View at publisher
Authors: Lixia Fan, Xinren Xu, Huimin Luo, Yuke Xiang, 黄百仙, J N Wang, Ruixue Wang
DOI: 10.1088/1748-605x/ae6e0e
Cited by: 1
References: 26

Abstract

Abstract Although chemotherapy remains a cornerstone of oncological treatment, its clinical application is severely hindered by the systemic toxicity and poor targeting efficiency inherent in conventional drug delivery systems. Given the relatively low levels of reactive oxygen species (ROS) in pathological tissues (

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Advanced Nanomaterials in Catalysis Nanoparticle-Based Drug Delivery

Publication details

Journal / source
Biomedical Materials
Publisher
IOP Publishing
Volume
21
Issue
3
Pages
035017–035017
Publication date
14 May 2026
Language
EN